Colfax Corporation Announces Q2 Results, Increased Full Year Outlook, and Strategic Acquisition

  • Reported $0.19 EPS from continuing operations and achieved $0.56 of adjusted EPS, raised FY 2021 adjusted EPS guidance range to $2.10-$2.20
  • Signed agreement to acquire Mathys Bettlach AG to expand fast-growing MedTech Reconstructive business outside of…

Click here to view the original article.